Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Imfinzi
Imfinzi
FDA clears AZ's Imfinzi for aggressive lung cancer
Pharmaphorum
Thu, 12/5/24 - 11:10 am
AstraZeneca
Imfinzi
small cell lung cancer
FDA
AstraZeneca’s Imfinzi and Imjudo found to extend survival in liver cancer trial
Clinical Trials Arena
Tue, 09/17/24 - 10:52 am
AstraZeneca
Imfinzi
Imjudo
liver cancer
clinical trials
ESMO: AstraZeneca's Imfinzi extends life in bladder cancer type. Will FDA push back on its perioperative trial design?
Fierce Pharma
Sun, 09/15/24 - 06:22 pm
ESMO
AstraZeneca
Imfinzi
bladder cancer
FDA approves AstraZeneca's non-small cell lung cancer treatment
Reuters
Thu, 08/15/24 - 10:06 pm
AstraZeneca
Imfinzi
FDA
non-small cell lung cancer
AstraZeneca’s Imfinzi-Lynparza Combo Wins Landmark EU Nod for Endometrial Cancer
BioSpace
Wed, 08/14/24 - 10:58 am
AstraZeneca
Europe
Imfinzi
Lynparza
endometrial cancer
FDA advisers, frustrated by AZ's Imfinzi design, call for revamp of perioperative lung cancer trials
Fierce Pharma
Thu, 07/25/24 - 09:59 pm
FDA
ODAC
clinical trials
non-small cell lung cancer
AstraZeneca
Imfinzi
FDA Flags Potential ‘Overtreatment’ for NSCLC With AstraZeneca’s Imfinzi Ahead of Adcomm
BioSpace
Wed, 07/24/24 - 11:32 am
AstraZeneca
Imfinzi
non-small cell lung cancer
FDA
AstraZeneca’s Imfinzi fails adjuvant trial in lung cancer
Pharmaphorum
Tue, 06/25/24 - 11:25 am
AstraZeneca
Imfinzi
clinical trials
non-small cell lung cancer
AstraZeneca Imfinzi plus chemotherapy gets US nod for certain type of endometrial cancer
Reuters
Mon, 06/17/24 - 11:31 am
AstraZeneca
Imfinzi
endometrial cancer
FDA
ASCO: AstraZeneca's Tagrisso, Imfinzi break new ground in lung cancer—with one standing ovation
Fierce Pharma
Mon, 06/3/24 - 12:10 pm
ASCO 2024
AstraZeneca
Tagrisso
Imfinzi
lung cancer
non-small cell lung cancer
As Bristol Myers reveals trial failure, AstraZeneca's Imfinzi stays king in stage 3 lung cancer
Fierce Pharma
Mon, 05/13/24 - 11:20 am
Bristol Myers Squibb
Opdivo
Yervoy
clinical trials
non-small cell lung cancer
AstraZeneca
Imfinzi
AIM ImmunoTech reports progress in pancreatic cancer drug trial
Clinical Trials Arena
Tue, 04/30/24 - 08:34 am
AIM ImmunoTech
clinical trials
Ampligen
Imfinzi
pancreatic cancer
AstraZeneca’s Imfinzi tackles another type of lung cancer with latest trial win
Fierce Pharma
Fri, 04/5/24 - 11:28 am
AstraZeneca
Imfinzi
clinical trials
limited-stage small cell lung cancer
AstraZeneca Shows Lynparza Combo Could Address Unmet Endometrial Cancer Need
BioSpace
Mon, 03/18/24 - 05:19 pm
AstraZeneca
Lynparza
Imfinzi
endometrial cancer
AstraZeneca reports positive data from Phase III trial of Imfinzi
Clinical Trials Arena
Mon, 01/22/24 - 11:29 am
AstraZeneca
Imfinzi
clinical trials
hepatocellular carcinoma
AstraZeneca charts new course for Imfinzi in liver cancer, but FDA path remains uncertain
Fierce Pharma
Fri, 01/19/24 - 11:13 am
AstraZenca
liver cancer
Imfinzi
AstraZeneca’s Imfinzi Phase III trial raises trial design questions
Clinical Trials Arena
Tue, 11/21/23 - 11:41 am
AstraZeneca
Imfinzi
clinical trials
AstraZeneca Bid to Expand Imfinzi’s NSCLC Label Hit with Phase III Flop
BioSpace
Tue, 11/14/23 - 10:55 am
AstraZeneca
Imfinzi
clinical trials
non-small cell lung cancer
AstraZeneca’s Imfinzi meets PFS primary endpoint in Phase III HCC trial
Clinical Trials Arena
Fri, 11/10/23 - 10:06 am
AstraZeneca
clinical trials
Imfinzi
hepatocellular carcinoma
Merck's Keytruda nabs FDA nod in biliary tract cancer, catching up with AstraZeneca's Imfinzi
Fierce Pharma
Wed, 11/1/23 - 10:10 pm
Merck
AstraZeneca
biliary tract cancer
Keytruda
Imfinzi
Pages
1
2
3
4
5
next ›
last »